Company · CIK 1906425
Invea Therapeutics, Inc
| CIK | 1906425 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CT |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292131 | 2025-12-15 | 2026-03-06 | 6 | |
| 333-275109 | 2023-10-20 | 2024-03-29 | 4 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-06 | RWWithdrawn | 333-292131 | 0001213900-26-024644 |
| 2026-01-30 | EFFECTDeclared effective | 333-292131 | 9999999995-26-000394 |
| 2026-01-27 | S-1/AAmendment | 333-292131 | 0001213900-26-008321 |
| 2026-01-23 | S-1/AAmendment | 333-292131 | 0001213900-26-007338 |
| 2026-01-07 | S-1/AAmendment | 333-292131 | 0001213900-26-001947 |
| 2025-12-15 | S-1Registration filed | 333-292131 | 0001213900-25-121387 |
| 2025-03-10 | DRSDraft made public | 377-07778 | 0001213900-25-022187 |
| 2024-03-29 | RWWithdrawn | 333-275109 | 0001104659-24-041142 |
| 2024-01-26 | S-1/AAmendment | 333-275109 | 0001104659-24-007237 |
| 2024-01-12 | S-1/AAmendment | 333-275109 | 0001104659-24-003696 |
| 2023-10-20 | S-1Registration filed | 333-275109 | 0001104659-23-110477 |
| 2023-08-07 | DRSDraft made public | 377-06807 | 0001104659-23-088247 |